Stilla Technologies

📍 Villejuif, France🗓 Founded 2013👥 101 employees💰 Last funded Sep 2023
Stilla Technologies is a leading global biotechnology company that focuses on accelerating development of next-generation genetic testing by providing researchers and clinicians with a flexible Digital PCR solution for high-resolution genetic analysis and assay development. Stilla’s next-generation Multiplex Crystal Digital PCR™ technology employs cutting-edge microfluidic innovations and integrates the entire dPCR process on a single chip. The naica® system is highly sensitive, fast, and features an easy workflow, higher levels of multiplexing, and intuitive software. Stilla developed the worlds first 6-color Digital PCR Platform, providing High Multiplexing and Sensitivity for Advancing Cancer & Liquid Biopsy Studies, Cell & Gene Therapies, Infectious Disease & COVID-19 Research, and Wastewater and Environmental Testing and many more applications. Stilla aims to make Digital PCR a lab commodity in all life sciences areas including research, therapeutics, and the omics. Visit the website and connect on Twitter @StillaTech
7
Total investors
0
Early stage
4
Mid stage
3
Late stage
2013
Founded
Investor geography2 countries
France
6
Luxembourg
1
Investor activity2018–2023 · investors recorded per year
20184202012021120231
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Stilla Technologies?
Stilla Technologies has 7 investors on record on gritt.io, 4 mid-stage and 3 late-stage investors.
When did Stilla Technologies last raise funding?
The most recent investment in Stilla Technologies recorded on gritt.io was in September 2023.
When was Stilla Technologies founded?
Stilla Technologies was founded in 2013.
What industry is Stilla Technologies in?
Stilla Technologies operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Stilla Technologies based?
Stilla Technologies is headquartered in Villejuif, France.